On the heels of losing a $73.4 million verdict in Texas state court, Boston Scientific Corp. is headed to trial next month in two federal courts over its pelvic mesh devices.
The company faces 13,000 of the 60,000 lawsuits that have been filed over transvaginal mesh devices, used to treat incontinence and pelvic organ prolapse in women. It goes to trial in federal court for the first time on Nov. 3 in both West Virginia and Florida.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
